HUMAHumacyte, Inc.Aug 12, 2026Q2 2026
Read transcript →Humacyte, Inc. (HUMA) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.44
+10.98%
Mkt Cap $114.76M
HUMAHumacyte, Inc.Aug 12, 2026HUMAHumacyte, Inc.May 13, 2026Q1 2026
Read transcript →HUMAHumacyte, Inc.Nov 12, 2025Q3 2025
Read transcript →HUMAHumacyte, Inc.Aug 11, 2025Q2 2025
Read transcript →HUMAHumacyte, Inc.May 13, 2025Q1 2025
Read transcript →HUMAHumacyte, Inc.Mar 28, 2025Q4 2024
Read transcript →HUMAHumacyte, Inc.Nov 9, 2024Q3 2024
Read transcript →HUMAHumacyte, Inc.Aug 13, 2024Q2 2024
Read transcript →HUMAHumacyte, Inc.May 10, 2024Q1 2024
Read transcript →HUMAHumacyte, Inc.Mar 22, 2024Q4 2023
Read transcript →HUMAHumacyte, Inc.Nov 10, 2023Q3 2023
Read transcript →HUMAHumacyte, Inc.Aug 14, 2023Q2 2023
Read transcript →HUMAHumacyte, Inc.May 12, 2023Q1 2023
Read transcript →HUMAHumacyte, Inc.Mar 27, 2023Q4 2022
Read transcript →HUMAHumacyte, Inc.Nov 10, 2022Q3 2022
Read transcript →HUMAHumacyte, Inc.Aug 12, 2022Q2 2022
Read transcript →HUMAHumacyte, Inc.May 13, 2022Q1 2022
Read transcript →HUMAHumacyte, Inc.Mar 29, 2022Q4 2021
Read transcript →